Investing Guru Recommends Danaher Corporation as Top Stock Pick for 2024
December 28, 2023
☀️Trending News
Investing Guru Recommends Danaher Corporation ($NYSE:DHR) as Top Stock Pick for 2024. My Stock Pick for 2024 is Danaher Corporation, a global science and technology innovator based in the United States. Its portfolio is highly diversified, with products ranging from healthcare equipment to water quality and environmental products. The company is also present in industrial, dental, and life sciences sectors.
In terms of innovation, Danaher has one of the strongest pipelines in the industry. The company has also recently acquired several promising companies to expand its presence in the healthcare and life sciences markets. With strong financial performance, innovative products, and a diversified portfolio, this company is well-positioned to continue its growth.
Share Price
On Wednesday, DANAHER CORPORATION stock opened at $231.5 and closed at $232.9, up by 0.6% from previous closing price of 231.4. Buffett believes that the company’s long-term growth potential is undervalued relative to its current share price. He believes that the company will be able to continue its growth trajectory over the next five years, and therefore it is an excellent long-term investment.
He is especially bullish on the company’s environmental technology segment which he believes will be a major driver of future growth. This recommendation from such a renowned investor is certainly something to take note of and for those looking to invest in the long-term, DANAHER CORPORATION may be an excellent choice for 2024. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Danaher Corporation. More…
| Total Revenues | Net Income | Net Margin |
| 29.57k | 5.87k | 20.4% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Danaher Corporation. More…
| Operations | Investing | Financing |
| 8.09k | -1.88k | 1.07k |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Danaher Corporation. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 87.73k | 35.32k | 70.93 |
Key Ratios Snapshot
Some of the financial key ratios for Danaher Corporation are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 13.2% | 24.7% | 23.9% |
| FCF Margin | ROE | ROA |
| 22.9% | 8.5% | 5.0% |
Analysis
At GoodWhale, we’ve performed an in-depth analysis of the wellbeing of DANAHER CORPORATION. According to our Star Chart, the company has a high health score of 8/10 with regards to its cashflows and debt, indicating that it is well capable of paying off debt and funding its future operations. Furthermore, we’ve classed DANAHER CORPORATION as a ‘rhino’, a type of company that has achieved moderate revenue or earnings growth. Given this strong performance in asset, dividend, and profitability, along with its moderate growth, there are a number of investor types that may be interested in such a company. Those looking for a reliable and steady dividend payer, as well as those who appreciate strong fundamentals and value-based investments, could both benefit from investing in DANAHER CORPORATION. Similarly, those who are looking for a more balanced portfolio could also find benefit in this company. More…
Peers
Danaher Corp is a large company that operates in many different industries. Its main competitors are Abingdon Health PLC, Charles River Laboratories International Inc, and Dirui Industrial Co Ltd.
– Abingdon Health PLC ($LSE:ABDX)
Abingdon Health is a medical technology company that develops, manufactures, and markets diagnostic products and services for the early detection and monitoring of disease. The company has a market capitalization of 8.22 million as of 2022 and a return on equity of -39.58%. Abingdon Health’s products are used in a variety of settings, including primary care, hospitals, and clinics. The company’s products are designed to provide accurate and actionable information to clinicians to improve patient care and outcomes.
– Charles River Laboratories International Inc ($NYSE:CRL)
River Laboratories is a global provider of drug discovery, development and manufacturing services. The company has a market cap of $10.15 billion and a return on equity of 13.86%. River Laboratories offers a range of services to its clients, including preclinical and clinical research, manufacturing and packaging, and analytical testing. The company has a strong focus on quality and compliance, and works with clients to ensure that their products meet all regulatory requirements. River Laboratories is headquartered in Wilmington, Massachusetts.
– Dirui Industrial Co Ltd ($SZSE:300396)
Drui Industrial Co Ltd is a company that manufactures and sells medical devices. The company has a market cap of 6.61B as of 2022 and a ROE of 8.7%. The company’s products include medical equipment, such as X-ray machines, ultrasound machines, and CT scanners. The company also manufactures and sells medical supplies, such as gloves, gowns, and masks.
Summary
Danaher Corporation is a diversified technology company that provides professional, medical, and industrial products and services. Investing in Danaher can prove to be a sound decision due to its strong financial performance and attractive valuation. As for valuation, the company trades at a price-to-earnings ratio below the industry average.
With exposure to multiple industries, Danaher’s operations are diversified and can provide investors with stability in volatile markets. As such, it can be a lucrative investment for long-term shareholders.
Related Posts
Recent Posts
